Medication info
Risendex Plus Tablet (Risendronate Sodium 2.5 Hydrate, Cholecalciferol Concentrate (Powder Form))

Risendex Plus Tablet (Risendronate Sodium 2.5 Hydrate, Cholecalciferol Concentrate (Powder Form))

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.162mg / 1 tabletCholecalciferol Concentrate Powder›56mg / 1 tablet
Manufacturer / importer
Hanlim Pharmaceutical Co., Ltd.
Appearance
Light orange oval film-coated tablet
Packaging
4 tablets (4 tablets/PTP packaging X 1)
Approval status
Active

MFDS item code 201004171 · Approved 2010.06.23 · Insurance code 645304150

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
1. Adults: Take 1 tablet orally once weekly 2. Elderly patients : No dosage adjustment is necessary in elderly patients (aged 60 years and older), since the bioavailability and pharmacokinetics of this medicine are similar to those in younger people. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with creatinine clearance of 30ml/min or higher. This medicine is contraindicated in patients with severe renal impairment and creatinine clearance below 30ml/min. Food interferes with absorption of this medicine. To ensure adequate absorption, take it as follows. Take at least 30 minutes before breakfast, or at any time of day, at least 2 hours before or after eating or drinking. To facilitate passage of this medicine into the stomach and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ~ 230ml). Taking it with other beverages, including mineral water, may reduce absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking the medicine. Patients with inadequate dietary intake of calcium and vitamin D should take supplements. Patients at increased risk of vitamin D deficiency (e.g., patients over 70 years of age, residents of nursing homes, and patients with chronic diseases) may need additional vitamin D supplements. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. This medicine provides one week's supply of 800 IU of vitamin D per day when taken once weekly. If a patient forgets to take the medicine on the scheduled day, take it on the day it is remembered. Take the next dose on the originally scheduled day. Do not take 2 tablets on the same day.
Child dose
3. Children : Safety and efficacy have not been established in children and growing adolescents.

Ingredients

Manufacturer
Hanlim Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men

  • Osteoporosis
View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women and for the treatment of osteoporosis in men.

How to take

Adult dose

1. Adults: Take 1 tablet orally once weekly 2. Elderly patients : No dosage adjustment is necessary in elderly patients (aged 60 years and older), since the bioavailability and pharmacokinetics of this medicine are similar to those in younger people. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with creatinine clearance of 30ml/min or higher. This medicine is contraindicated in patients with severe renal impairment and creatinine clearance below 30ml/min. Food interferes with absorption of this medicine. To ensure adequate absorption, take it as follows. Take at least 30 minutes before breakfast, or at any time of day, at least 2 hours before or after eating or drinking. To facilitate passage of this medicine into the stomach and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ~ 230ml). Taking it with other beverages, including mineral water, may reduce absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking the medicine. Patients with inadequate dietary intake of calcium and vitamin D should take supplements. Patients at increased risk of vitamin D deficiency (e.g., patients over 70 years of age, residents of nursing homes, and patients with chronic diseases) may need additional vitamin D supplements. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. This medicine provides one week's supply of 800 IU of vitamin D per day when taken once weekly. If a patient forgets to take the medicine on the scheduled day, take it on the day it is remembered. Take the next dose on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

3. Children : Safety and efficacy have not been established in children and growing adolescents.

Precautions

This drug can irritate the stomach and esophagus, and may cause issues like esophagitis or esophageal ulcers if taken incorrectly. Do not lie down for at least 30 minutes after taking, and take with a sufficient amount of water. If you have esophageal problems or have difficulty swallowing, discontinue use and consult a doctor. Since a balance of calcium and vitamin D is important, patients with hypocalcemia must receive treatment before using this medication. Moreover, this drug should not be used in patients with certain genetic disorders or severe renal impairment. Rarely, there may be skin rashes, allergic reactions, muscle pain, joint pain, gastrointestinal disturbances, and if strange symptoms occur, you should notify your doctor. If dental treatment is necessary, notify your doctor in advance due to the risk of jaw necrosis. Women who are pregnant or breastfeeding must consult a doctor before taking this medication, and safety in pediatric patients has not been established. Be cautious as taking this medication with other medications or food that contain calcium, magnesium, or iron may hinder absorption. In cases of overdose, hypocalcemia symptoms may occur, requiring immediate medical attention. Finally, keep this medication out of the reach of children and strictly adhere to the prescribed dosage and administration methods.

Side effects

  • esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • perforation
  • bleeding
  • gastric ulcer
  • duodenitis
  • glossitis
  • decreased blood calcium
Show 77 more
  • decreased blood phosphate
  • bone pain
  • joint pain
  • muscle pain
  • depression
  • dizziness
  • insomnia
  • anxiety
  • neuralgia
  • vertigo
  • tension increase
  • sensory abnormalities
  • pharyngitis
  • rhinitis
  • dyspnea
  • pneumonia
  • rash
  • itching
  • skin cancer
  • cataract
  • conjunctivitis
  • otitis media
  • urinary tract infection
  • cystitis
  • injury due to accident
  • epidemic cold syndrome
  • headache
  • overdose
  • allergic reaction
  • fainting
  • vasodilation
  • constipation
  • dyspepsia
  • nausea
  • diarrhea
  • gastroenteritis
  • colitis
  • vomiting
  • thirst
  • peripheral edema
  • traumatic fracture
  • muscle strain
  • arthritis
  • bursitis
  • bronchitis
  • sinusitis
  • increased cough
  • fever
  • falling
  • dizziness
  • bronchitis
  • sinusitis
  • increased cough
  • facial edema
  • hair loss
  • dysosmia
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • angioedema
  • blister
  • jaw necrosis
  • liver dysfunction
  • jaundice
  • external auditory canal necrosis
  • loss of appetite
  • asthenia
  • heartburn
  • epigastric pain
  • discomfort in the chest
  • palpitations
  • increased sweating
  • facial flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius to preserve the medication's effectiveness and safety.

Appearance and packaging

Appearance

Light orange oval film-coated tablet

Package unit

4 tablets (4 tablets/PTP packaging X 1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.